SciTech Development LLC
🇺🇸United States
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1
Recruiting
- Conditions
- Cutaneous T-cell LymphomaSézary's DiseaseCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell LymphomaPrimary Cutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, UnspecifiedAngioimmunoblastic T-cell LymphomaT-cell LymphomaPeripheral T-Cell Lymphoma, Not ClassifiedFollicular T-Cell Lymphoma
- Interventions
- First Posted Date
- 2020-01-21
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- SciTech Development, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT04234048
- Locations
- 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇺🇸City of Hope Medical Foundation, Duarte, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
News
No news found